Targeted Therapy Technologies, LLC
5 clinical trials · Sponsor
◉ Watch Targeted Therapy Technologies, LLC
| Record | Firm | Date |
|---|---|---|
| Retinoblastoma Phase II Expanded Access Clinical Trial (NCT06679634) | Targeted Therapy Technologies, LLC | 2025-02-21 |
| Topotecan Episcleral Plaque for Treatment of Retinoblastoma (NCT04156347) | Targeted Therapy Technologies, LLC | 2021-06-16 |
| Phase I Study of Episcleral Celecoxib for Treatment of Macular Edema and Inflammatory Disorders of the Posterior Pole (NCT04120636) | Targeted Therapy Technologies, LLC | 2021-03-05 |
| Episcleral Dexamethasone for Treatment of Macular Edema and Inflammatory Disorders of the Posterior Pole (NCT04120311) | Targeted Therapy Technologies, LLC | 2019-09-01 |
| A Phase I Study of Episcleral Dexamethasone for Treatment of Macular Edema (NCT04005430) | Targeted Therapy Technologies, LLC | 2019-04-03 |
Track Targeted Therapy Technologies, LLC automatically
Every clearance here is in the API, with alerts when new ones post.